Intrinsiqs

Is Regeneron Pharmaceuticals, Inc. overvalued?

Regeneron Pharmaceuticals, Inc. (REGN) looks fairly valued — trading about 3% above its fair value.

Fairly valued
Current price $797.99 Fair value $773.52
Price
$797.99
Fair value
$773.52
Current P/E
19.2
Normal P/E
18.6
Market cap
$82.21B
Dividend yield
0.5%
Return on equity
13.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares REGN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedRHHBY Roche Holding AGMRK Merck & Co., Inc.